Cargando…

The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM

PRACTICAL RELEVANCE: Although feline hypertrophic cardiomyopathy (HCM) occurs more commonly, dilated cardiomyopathy (DCM), restrictive cardiomyopathy (RCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), left ventricular noncompaction (LVNC) and cardiomyopathy – nonspecific phenotype (NCM;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kittleson, Mark D, Côté, Etienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Clinical Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723175/ https://www.ncbi.nlm.nih.gov/pubmed/34693805 http://dx.doi.org/10.1177/1098612X211030218

Ejemplares similares

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

The Feline Cardiomyopathies: 1. General concepts
por: Kittleson, Mark D, et al.
Publicado: (2021)

Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM
por: Freeman, Lisa M., et al.
Publicado: (2017)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
por: Melas, Marilena, et al.
Publicado: (2022)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Vigorous Exercise in Patients with Hypertrophic Cardiomyopathy: Results of the Prospective, Observational, Multinational, “Lifestyle and Exercise in HCM” (LIVE-HCM) Study
por: Lampert, Rachel, et al.
Publicado: (2023)

Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA)
por: Guttmann, Oliver P., et al.
Publicado: (2015)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Quality of life and societal costs in hypertrophic cardiomyopathy: protocol of the AFFECT-HCM study
por: Schoonvelde, Stephan A. C., et al.
Publicado: (2023)

Adult Onset Hypertrophic Cardiomyopathy (HCM) Not Detected by Echocardiogram: A Case Presentation
por: Elsouri, Kawther N, et al.
Publicado: (2023)

Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
por: Sado, Daniel, et al.
Publicado: (2013)

Venous dysfunction in obstructive hypertrophic cardiomyopathies: Results from the “HCM-Vein” pilot study
por: Réant, Patricia, et al.
Publicado: (2023)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death
por: Dass, Sairia, et al.
Publicado: (2012)

Identification of Potential miRNA-mRNA Regulatory Network Contributing to Hypertrophic Cardiomyopathy (HCM)
por: Wang, Lin, et al.
Publicado: (2021)

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Histopathology in HCM
por: Tejado, Beatriz San Millán, et al.
Publicado: (2018)

Cardiac magnetic resonance imaging (CMR) characteristics in apical versus non-apical hypertrophic cardiomyopathy (HCM)
por: Dastidar, Amardeep Ghosh, et al.
Publicado: (2016)

Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy
por: Stec, Maria, et al.
Publicado: (2023)

ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats
por: Luis Fuentes, Virginia, et al.
Publicado: (2020)

Association between Lifelong Physical Activity and Disease Characteristics in HCM
por: AENGEVAEREN, VINCENT L., et al.
Publicado: (2019)

Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model
por: Bhattacharya, Moumita, et al.
Publicado: (2021)

Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs
por: Montag, J., et al.
Publicado: (2018)

Heart Transplantation for Adriamycin Cardiomyopathy: The Plural of Anecdote and the Power of Registries
por: Kittleson, Michelle M.
Publicado: (2021)

Follow-up and prognosis of HCM
por: Dominguez, Fernando, et al.
Publicado: (2018)

Deep learning-based diagnosis of feline hypertrophic cardiomyopathy
por: Rho, Jinhyung, et al.
Publicado: (2023)

Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy
por: Kübler, J., et al.
Publicado: (2021)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
por: Bhatti, Sabha, et al.
Publicado: (2012)

Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial
por: Reaney, Matthew, et al.
Publicado: (2022)

Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM): A Study from the ClinGen Cardiomyopathy Variant Curation Expert Panel
por: Morales, Ana, et al.
Publicado: (2021)

Exploration of Mediators Associated with Myocardial Remodelling in Feline Hypertrophic Cardiomyopathy
por: Cheng, Wan-Ching, et al.
Publicado: (2023)

Platelet Activation in Cats with Hypertrophic Cardiomyopathy
por: Tablin, F., et al.
Publicado: (2014)

Myocarditis caused by Feline Immunodeficiency Virus in Five Cats with Hypertrophic Cardiomyopathy
por: Rolim, V. Machado, et al.
Publicado: (2016)

EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM): A prospective observational study on incidence of arrhythmias
por: Magnusson, Peter, et al.
Publicado: (2020)

Perspectives on current recommendations for genetic testing in HCM
por: Monserrat, Lorenzo
Publicado: (2018)

Electrocardiographic findings in peripartum cardiomyopathy
por: Honigberg, Michael C., et al.
Publicado: (2019)

Takotsubo or Stress Cardiomyopathy
por: Bounhoure, J. P.
Publicado: (2012)

DIAGNOSTIC DILEMMA: COVID-19 RELATED CARDIOMYOPATHY OR PERIPARTUM CARDIOMYOPATHY?
por: Addo, Basilio, et al.
Publicado: (2021)

Not all LGE is the same. Scar contrast volume of distribution is lower in HCM than in infarction
por: Treibel, Thomas A, et al.
Publicado: (2012)

Heart rate as an early predictor of severe cardiomyopathy and increased mortality in peripartum cardiomyopathy
por: Cooney, Ryan, et al.
Publicado: (2022)

Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy
por: Stankowski, Kamil, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ofqsf9s6eeq338udnt6ejee7o